NCT00864565View on ClinicalTrials.gov

A Relative Bioavailability Study of Fentanyl 25 μg/h Transdermal System

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

June 30, 2003

Study Completion Date

June 30, 2003

Conditions
Healthy
Interventions
DRUG

Fentanyl 25 μg/h transdermal system, single application

A: Experimental Subjects received Corium International, Inc formulated products

DRUG

Duragesic 25 μg/h transdermal system single application

B: Active comparator Subjects received Jassen Pharmaceutica Products, L.P. formulated products

Trial Locations (1)

G1V2K8

Anapharm Inc, Québec

Sponsors

Lead Sponsor

Actavis Inc.
All Listed Sponsors
lead

Actavis Inc.

INDUSTRY